MedTrace Logo

Vitamin Deficiency in Immigrants, a Treatment Study

NCT01419119 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 160

Last updated 2024-07-18

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine the efficacy of different doses of vitamin D in persons, immigrated to Sweden from Middle East or Africa, with decreased S vitamin D.

Conditions

  • Vitamin D Deficiency

Interventions

DRUG

Cholecalciferol high dose at Vitamin D deficiency

10 000 IU daily i.e. 15 drops orally once daily for 12 weeks

DRUG

Cholecalciferol median dose at Vitamin D insufficiency

2000 IU daily i.e. 3 drops orally once a day for 12 weeks,

DRUG

Cholecalciferol low dose at Vitamin D deficiency

2000 IU once a week i.e. 3 drops orally once a week (the same day every week) for 12 weeks,

DRUG

Cholecalciferol median dose at sufficient Vitamin D level

2000 IU daily i.e. 3 drops orally once daily for 12 weeks

Sponsors & Collaborators

  • Umeå University

    lead OTHER

Principal Investigators

  • Margareta Norberg, M.D. Ph.D · Dept of Epidemiology and Global Health, Umeå University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
25 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-09-30
Primary Completion
2012-10-31
Completion
2012-10-31

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01419119 on ClinicalTrials.gov